Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2012
05/02/2012CN102429889A Large ring lactone type medicament capsule and preparation method thereof
05/02/2012CN102429887A Sodium-potassium citrate chewing tablet and preparation method thereof
05/02/2012CN102429886A Indapamide osmotic pump preparation and preparation method thereof
05/02/2012CN102429885A DC (Directly compressible)-xylitol and preparation method thereof
05/02/2012CN102429884A Methylphenidate hydrochloride oral cavity disintegrating pharmaceutical composition
05/02/2012CN102429883A Fluoxetine hydrochloride oral cavity disintegrating pharmaceutical composition
05/02/2012CN102429882A Gabapentin prodrug sustained release oral dosage forms
05/02/2012CN102429879A Ambroxol hydrochloride liposome injection
05/02/2012CN102429878A Calcium folinate for injection and production technology for calcium folinate
05/02/2012CN102429877A Double-targeting-function medicament sustained-release system prepared by supercritical fluid technique
05/02/2012CN102429876A Liraglutide sustained-release microsphere preparation and preparation method thereof
05/02/2012CN102429875A Cyclosporin A pulmonary inhaled macroporous microspheres and preparation method thereof
05/02/2012CN102429874A Nifedipine framework sustained-release pellets and preparation method and application thereof
05/02/2012CN102429871A Enteric slow-released granules for promoting intestinal absorption
05/02/2012CN102429870A Novel tumor-targeting arboraceous polymer nano carrier of camptothecin drug
05/02/2012CN102429869A Preparation method of stearic acid drug-loading micro-nanoparticle loaded with drug with controllable packing degree
05/02/2012CN102429868A Liposome medicinal composition with tumor targeting, in-vivo tracing and treating functions and preparation method thereof
05/02/2012CN102429867A Dex-ibuprofen injectable suspension and preparation method thereof
05/02/2012CN102429866A Preparation formula of ibuprofen oral solution capable of being prepared into frozen form for taking
05/02/2012CN102429862A Sustained-release povidone iodine eye drops
05/02/2012CN102429858A Preparation method and application of sustained-release BIO/IGF (6-bromoindirubin-3'-oxime/insulin-like growth factor) composite hydrogel
05/02/2012CN102429834A Artificial nail compositions and related methods
05/02/2012CN102429825A Natural biomineralization powder, preparation method thereof and application thereof
05/02/2012CN102204884B Composition preparation of ofloxacin compound and mannitol, and preparation method thereof
05/02/2012CN102106833B Pemetrexed disodium freeze-dried powder injection and preparation method thereof
05/02/2012CN102038639B Alprostadil injection preparation
05/02/2012CN102030898B ABC-type amphiphilic biodegradable polyester triblock copolymer and preparation method and application thereof
05/02/2012CN101983668B Shiqi exogenous traditional Chinese medicine tablet
05/02/2012CN101972451B Compound infusion preparation of Chinese herbal medicines and western medicines for treating cow hysteritis and preparation method thereof
05/02/2012CN101972260B Rosuvastatin calcium oral drug composition
05/02/2012CN101961403B Combined Chinese medicinal ointment for treating hemorrhoids
05/02/2012CN101912491B Pills for treating cardiovascular diseases and preparation method
05/02/2012CN101905025B Preparation method for protective agent of intestinal mucosal barrier
05/02/2012CN101890078B Traditional Chinese medicinal tablets for treating lumbar spinal stenosis and production method thereof
05/02/2012CN101700243B Novel medicine carrying woundplast with treating function
05/02/2012CN101695488B Compound articaine freeze-drying preparation for injection and preparation method thereof
05/02/2012CN101636156B Pharmaceutical alkyl gallate composition.
05/02/2012CN101612188B Preparation method and product of eucommia bark depressor Chinese medicament sustained release preparation
05/02/2012CN101502641B Ciclosporin medicament composition for injection administration
05/02/2012CN101485695B Guiling dispersible tablets and preparation method thereof
05/02/2012CN101485675B Adapalene and hydrochloric clindamycin compound gel preparation and preparation method thereof
05/02/2012CN101316593B Formulations of quinolinones
05/02/2012CN101198331B Solubilization preparation
05/02/2012CN101045156B Special target medicine and its use
05/02/2012CA2719855A1 Temperature sensitive hydrogel and block copolymers
05/01/2012USRE43331 Stabilized liquid protein formulations in pharmaceutical containers
05/01/2012US8168776 Method for making a 21 nucleotide double stranded RNA chemically linked at one end
05/01/2012US8168682 Personal product bar compositions comprising crystalline wax structured premix or delivery vehicle
05/01/2012US8168628 Conjugated psychotropic drugs and uses thereof
05/01/2012US8168600 Compositions and methods for topical delivery of oligonucleotides
05/01/2012US8168599 Composition and method for healing tissues
05/01/2012US8168598 Optimised formulation of tobramycin for aerosolization
05/01/2012US8168410 Anti-IGF-IR antibodies and uses thereof
05/01/2012US8168248 Food intermediate having sequestered phytosteryl esters in a polysaccharide matrix
05/01/2012US8168223 Engineered particles and methods of use
05/01/2012US8168222 Amphiphilic polymer-protein conjugates and methods of use thereof
05/01/2012US8168217 Sucrose acetate isobutyrate; cellulose acetate butyrate; solvent; rheology modifier; opioid drug; dosage form and formulation; desirable release kinetics; not susceptible to crushing or powdering; not susceptible to extraction using ethanol or water; abuse deterrence and reduced risk of diversion
05/01/2012US8168187 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer
05/01/2012US8168186 Therapeutic using a bispecific antibody
05/01/2012US8168159 Compounds for tumor diagnosis and therapy
05/01/2012CA2550811C Temperature-stable formulations, and methods of development thereof
05/01/2012CA2532648C A stable clozapine suspension formulation
05/01/2012CA2528988C Stable, aqueous solution of human erythropoietin, not containing serum albumin
05/01/2012CA2516455C Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
05/01/2012CA2508831C Immunoconjugates with an intracellularly-cleavable linkage
05/01/2012CA2485217C Insulin-associated peptides with effects on cerebral health
05/01/2012CA2478871C Preparations for topical skin use and treatment
05/01/2012CA2475092C Nanoparticulate compositions having lysozyme as a surface stabilizer
05/01/2012CA2455633C Sustained-release therapeutic bioadhesive systems
05/01/2012CA2379858C Beta-amyloid peptide inhibitors
04/2012
04/26/2012WO2012054923A2 Therapeutic nanoparticles with high molecular weight copolymers
04/26/2012WO2012054861A1 Glp-1 polymer conjugates having a releasable linkage
04/26/2012WO2012054822A1 Pharmacologically active polymer-glp-1 conjugates
04/26/2012WO2012054748A2 Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the pi3k-akt mtor pathway
04/26/2012WO2012054742A2 Implantable polymer for bone and vascular lesions
04/26/2012WO2012054717A2 Detecting and treating solid tumors through selective disruption of tumor vasculature
04/26/2012WO2012054564A2 Anti-vegf antibody/fragment conjugated gold nanoparticles, and fabrication and therapeutic methods
04/26/2012WO2012054500A2 Compositions for drug administration
04/26/2012WO2012054447A2 Use of storage stable viscous phospholipid depot to treat wounds
04/26/2012WO2012054376A2 Metal ion nanoclusters
04/26/2012WO2012054067A1 Benzonatate compositions and methods of use
04/26/2012WO2012053785A2 Sustained-release pellets containing tacrolimus as an active ingredient
04/26/2012WO2012053703A1 Composition for enteric hard capsules, and enteric hard capsule preparedusing the composition
04/26/2012WO2012053654A1 Sustained-release formulation for injection
04/26/2012WO2012053012A2 Topical pharmaceutical compositions comprising tfflocolchicoside
04/26/2012WO2012053007A1 Topical pharmaceutical compositions containing nanodroplets for the treatment psoriasis
04/26/2012WO2012052898A1 Lipid vectors delivering gene silencers
04/26/2012WO2012052527A1 Pendant hydrophile bearing biodegradable compositions and related devices
04/26/2012WO2012052479A2 Brimonidine gel compositions and methods of use
04/26/2012WO2012052472A1 Pharmaceutical topical composition of mupirocin
04/26/2012WO2012052418A1 Liquid pharmaceutical composition for the delivery of active ingredients
04/26/2012WO2012030895A3 Hemostatic compositions and methods of making
04/26/2012WO2012024405A3 Curcumin compositions and uses thereof
04/26/2012WO2012018240A3 Preparation of extremely small and uniform sized, iron oxide-based paramagnetic or pseudo-paramagnetic nanoparticles and mri t1 contrast agents using the same
04/26/2012WO2012017006A3 Use of a n-vinyllactam / vinylimidazol copolymer as dispersing agent
04/26/2012WO2012004684A3 Guanidinylated aminoglycoside -lipid conjugates
04/26/2012WO2012002745A3 Factor viia complex using an immunoglobulin fragment
04/26/2012WO2011156242A3 Improved anti-lysophospholipid antibody design using antibody structures
04/26/2012WO2011110939A3 Pharmaceutical compositions of substituted benzhydrylpiperazines
04/26/2012WO2011053252A1 Polymer coated magnetic particles
1 ... 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 ... 1712